Marcin Mankowski is the Managing Partner of tranScrip, of which he was a co-founder in 2008. He is a drug development expert in the areas of infectious diseases and respiratory medicine.
Marcin has worked in the pharmaceutical industry for 26 years and has held a number of senior positions in big pharma and biotech companies. He has been involved in the development, registration and launch of many products. Marcin’s experience includes strategy for early development programmes from pre-clinical to proof-of concept studies, design and management of clinical trials, preparation and defence of regulatory submissions in Europe, US and Asia. Marcin supported the regulatory and clinical strategy for many antibacterials, antifungals and antivirals, and led preparation of several successful MAAs/NDAs.
Marcin graduated from the Medical University in Warsaw, where he worked for several years in pneumonology and infectious diseases departments. He is board-certified in Internal Medicine.
Before co-founding tranScrip, he held several positions at Bristol-Myers Squibb, where he worked as the Director of Clinical Research for Infectious Diseases and also as the European Medical Lead for HIV. He later worked at Chiron Biopharmaceuticals as the Senior Director for Infectious Diseases and General Medicine, responsible for drug development and medical affairs activities in Europe.
In 2022, in recognition of his long-standing contribution to pharmaceutical medicine, Marcin was awarded Membership of the Faculty of Pharmaceutical Medicine by Distinction.
Marcin is a member of the European Society of Clinical Microbiology and Infectious Diseases.